Mononuclear cell infiltrate and HLA-Dr expression in 28 pituitary adenomas
- PMID: 2284689
- DOI: 10.1177/030089169007600605
Mononuclear cell infiltrate and HLA-Dr expression in 28 pituitary adenomas
Abstract
Frozen sections from 28 pituitary adenomas were reached with a panel of monoclonal antibodies to macrophages, lymphocytes and HLA-Dr invariant chain. A low number of macrophages were demonstrated in all tumors, mainly perivascular. CD8 and CD4 lymphocytes were detected in even smaller numbers in 80% and 14% of tumors respectively. B lymphocytes were present in only 1 case. An occasional NK cell was present in 1/13 cases studied. HLA-Dr antigen was expressed by macrophages in all cases and by tumor cells in 2 growth hormone-producing adenomas/19 adenomas. These findings may represent evidence for a low degree of cellular immune response to pituitary adenomas.
Similar articles
-
Differential expression of HLA-DR, HLA-DP, HLA-DQ and associated invariant chain (Ii) in normal colorectal mucosa, adenoma and carcinoma.Virchows Arch A Pathol Anat Histopathol. 1988;412(4):315-22. doi: 10.1007/BF00750257. Virchows Arch A Pathol Anat Histopathol. 1988. PMID: 3125670
-
Immune Cell Infiltrates in Pituitary Adenomas: More Macrophages in Larger Adenomas and More T Cells in Growth Hormone Adenomas.Endocr Pathol. 2015 Sep;26(3):263-72. doi: 10.1007/s12022-015-9383-6. Endocr Pathol. 2015. PMID: 26187094
-
Mononuclear cell infiltrate and HLA-Dr expression in intra- and extradural secondary carcinomas.Pathol Res Pract. 1991 Jan;187(1):55-61. doi: 10.1016/s0344-0338(11)81045-9. Pathol Res Pract. 1991. PMID: 2027823
-
Tumor-Associated Macrophages: New Horizons for Pituitary Adenoma Researches.Front Endocrinol (Lausanne). 2021 Dec 2;12:785050. doi: 10.3389/fendo.2021.785050. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34925244 Free PMC article. Review.
-
The Progress of Immunotherapy in Refractory Pituitary Adenomas and Pituitary Carcinomas.Front Endocrinol (Lausanne). 2020 Dec 11;11:608422. doi: 10.3389/fendo.2020.608422. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 33362722 Free PMC article. Review.
Cited by
-
Research advances on the immune research and prospect of immunotherapy in pituitary adenomas.World J Surg Oncol. 2021 Jun 5;19(1):162. doi: 10.1186/s12957-021-02272-9. World J Surg Oncol. 2021. PMID: 34090476 Free PMC article. Review.
-
Chemokines modulate the tumour microenvironment in pituitary neuroendocrine tumours.Acta Neuropathol Commun. 2019 Nov 8;7(1):172. doi: 10.1186/s40478-019-0830-3. Acta Neuropathol Commun. 2019. PMID: 31703742 Free PMC article.
-
Increased expression of programmed death ligand 1 (PD-L1) in human pituitary tumors.Oncotarget. 2016 Nov 22;7(47):76565-76576. doi: 10.18632/oncotarget.12088. Oncotarget. 2016. PMID: 27655724 Free PMC article.
-
Tumour microenvironment and pituitary tumour behaviour.J Endocrinol Invest. 2023 Jun;46(6):1047-1063. doi: 10.1007/s40618-023-02089-1. Epub 2023 Apr 15. J Endocrinol Invest. 2023. PMID: 37060402 Review.
-
Lactate-induced M2 polarization of tumor-associated macrophages promotes the invasion of pituitary adenoma by secreting CCL17.Theranostics. 2021 Feb 6;11(8):3839-3852. doi: 10.7150/thno.53749. eCollection 2021. Theranostics. 2021. PMID: 33664865 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials